Seed Intellectual Property Law Group LLP
PKM2 modulators and methods for their use
Compounds having activity as PKM2 activators are disclosed. The compounds have the following structure (I): including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed. 
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
C C C C A C C C C C C C C A A C C A C
C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07F C07D C07D A61P A61P C07D C07D A61K C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Michael David Kevin Bret Scott Albert Kenneth Mark Steven Brian David Lee Koc-Kan Xiaohui Jason Marc Jihua Yong
Saunders Wright Pearce Parnell Kanner Vollmer Ho Liu Foulks Liu Xu